Literature DB >> 18640844

Fluorinated phenylcyclopropylamines. Part 5: Effects of electron-withdrawing or -donating aryl substituents on the inhibition of monoamine oxidases A and B by 2-aryl-2-fluoro-cyclopropylamines.

Svenja Hruschka1, Thomas C Rosen, Shinichi Yoshida, Kenneth L Kirk, Roland Fröhlich, Birgit Wibbeling, Günter Haufe.   

Abstract

A series of racemic, diastereoisomeric aryl cyclopropylamines substituted with fluorine in the 2-position and electron-donating and electron-withdrawing groups on the aromatic ring have been prepared. These represent analogues of the classic MAO inhibitor tranylcypromine (trans-2-phenylcyclopropylamine, 1). Their activities as inhibitors of recombinant human liver monoamine oxidases A (MAO A) and B (MAO B) were determined. The trans-compounds were low micromolar inhibitors of both MAO A and MAO B with moderate MAO A selectivity while the less active cis-analogues were MAO B selective. In the trans-series, electron-withdrawing para-substituents increased the potency of MAO A inhibition while electron-donating groups such as methyl or methoxy had no influence on this activity. In contrast, aromatic ring substitution in the trans-series had essentially no effect on the inhibition of MAO B. The corresponding cis-compounds were shown to be 10-100 times less active against MAO A, while trans- and cis-compounds were quite similar in terms of inhibition of MAO B. The best MAO A/MAO B selectivity (7:1) in the trans-series was found for trans-2-fluoro-2-(para-trifluoromethylphenyl)cyclopropylamine (7d), while a 1:27 selectivity was found for cis-2-fluoro-2-(para-fluorophenyl)cyclopropylamine (10c). These results are discussed in connection with the pK(a) and logD values, the mechanism of action of tranylcypromines, and the geometry of the active site of the enzymes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18640844      PMCID: PMC2613070          DOI: 10.1016/j.bmc.2008.06.048

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  47 in total

Review 1.  Monoamine oxidase: radiotracer development and human studies.

Authors:  Joanna S Fowler; Jean Logan; Nora D Volkow; Gene-Jack Wang; Robert R MacGregor; Yu-Shin Ding
Journal:  Methods       Date:  2002-07       Impact factor: 3.608

Review 2.  The therapeutic potential of monoamine oxidase inhibitors.

Authors:  Moussa B H Youdim; Dale Edmondson; Keith F Tipton
Journal:  Nat Rev Neurosci       Date:  2006-04       Impact factor: 34.870

3.  Kinetic studies on the catalytic mechanism of liver monoamine oxidase.

Authors:  M Husain; D E Edmondson; T P Singer
Journal:  Biochemistry       Date:  1982-02-02       Impact factor: 3.162

4.  Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid.

Authors:  R M Geha; I Rebrin; K Chen; J C Shih
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

5.  Functional role of the "aromatic cage" in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins.

Authors:  Min Li; Claudia Binda; Andrea Mattevi; Dale E Edmondson
Journal:  Biochemistry       Date:  2006-04-18       Impact factor: 3.162

6.  Mechanism-based inactivation of mitochondrial monoamine oxidase by N-(1-methylcyclopropyl)benzylamine.

Authors:  R B Silverman; R B Yamasaki
Journal:  Biochemistry       Date:  1984-03-13       Impact factor: 3.162

7.  Inhibition of rat aorta semicarbazide-sensitive amine oxidase by 2-phenyl-3-haloallylamines and related compounds.

Authors:  G A Lyles; C M Marshall; I A McDonald; P Bey; M G Palfreyman
Journal:  Biochem Pharmacol       Date:  1987-09-01       Impact factor: 5.858

8.  Fluorinated phenylcyclopropylamines. 1. Synthesis and effect of fluorine substitution at the cyclopropane ring on inhibition of microbial tyramine oxidase.

Authors:  Shinichi Yoshida; Oliver G J Meyer; Thomas C Rosen; Günter Haufe; Song Ye; Milton J Sloan; Kenneth L Kirk
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

9.  Crystal structures of monoamine oxidase B in complex with four inhibitors of the N-propargylaminoindan class.

Authors:  Claudia Binda; Frantisek Hubálek; Min Li; Yaacov Herzig; Jeffrey Sterling; Dale E Edmondson; Andrea Mattevi
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

10.  Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin.

Authors:  F Boomsma; F H Derkx; A H van den Meiracker; A J Man in 't Veld; M A Schalekamp
Journal:  Clin Sci (Lond)       Date:  1995-06       Impact factor: 6.124

View more
  2 in total

Review 1.  Kinetics, mechanism, and inhibition of monoamine oxidase.

Authors:  Rona R Ramsay; Alen Albreht
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

2.  Fluorinated phenylcyclopropylamines. Part 6: Effects of electron withdrawing or donating aryl substituents on the inhibition of tyramine oxidase from Arthrobacter sp. by diastereomeric 2-aryl-2-fluoro-cyclopropylamines.

Authors:  Svenja Hruschka; Shinichi Yoshida; Kenneth L Kirk; Günter Haufe
Journal:  J Fluor Chem       Date:  2008-09       Impact factor: 2.050

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.